Dassault Systèmes SE Stock
€36.02
Your prediction
Dassault Systèmes SE Stock
Pros and Cons of Dassault Systèmes SE in the next few years
Pros
Cons
Performance of Dassault Systèmes SE vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Dassault Systèmes SE | -1.310% | -0.277% | 5.352% | 2.300% | -18.755% | -27.895% | 38.538% |
Cap Gemini S.A. | -3.640% | -2.941% | 3.722% | 11.203% | -1.026% | -0.265% | 76.703% |
Akamai Tech. | -0.730% | 0.236% | -2.515% | -11.708% | -17.187% | -3.695% | 9.697% |
Gartner Inc. | -0.850% | -0.130% | 5.190% | 38.210% | 12.521% | 72.970% | 253.054% |
News
Medidata Recognized as a Leader in Everest Group’s Inaugural Electronic Data Capture PEAK Matrix® Assessment
Medidata, a Dassault Systèmes brand and the leading provider of clinical trial solutions to the life sciences industry, has been recognized as a Leader in Everest Group‘s first-ever PEAK Matrix®
EORTC Extends Medidata Partnership to Help Power New Phase of Oncology Research
Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, and the European Organisation for Research and Treatment of Cancer (EORTC)
Aixial Group Migrates Specific Clinical Data Portfolio Onto Medidata Platform to Create a Single Source of Truth and Accelerate Database Lock
Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today announced a new project with Aixial Group, a contract research organization